DADE BEHRING INC
8-K, 1999-05-11
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: SIMCALA INC, 10-Q, 1999-05-11
Next: R B RUBBER PRODUCTS INC, SC 13D, 1999-05-11






                   SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C.  20549
                      ___________________________




                                FORM 8-K

                             CURRENT REPORT




                 Pursuant to Section 13 or 15(d) of the
                    Securities Exchange Act of 1934

                      ___________________________

     Date of Report (Date of earliest event reported) May 11, 1999




                           DADE BEHRING INC.
____________________________________________________________


         (Exact name of registrant as specified in its charter)


      Delaware                 333-13523          36-3949533
(State or other jurisdiction  (Commission        (IRS Employer
   of incorporation)          File Number)    Identification No.)

   1717 Deerfield Road, Deerfield Illinois        60015-0778
   (Address of principal executive offices)       (Zip Code)

____________________________________________________________

                        Exhibit Index on Page 2
<PAGE>
Item 5  Other Events

        The Registrant is a wholly-owned subsidiary of Dade Behring
        Holdings, Inc. which announced a share repurchase program.

        The Registrant announced a number of executive changes, including
        the appointment of James W.P. Reid-Anderson as its President and
        Chief Operating Officer.

Item 7  Financial Statements, Pro Forma Financial Information and
        Exhibits

        (c) Exhibits

            99.1  Press Release related to the Dade Behring Holdings,
                  Inc. share repurchase program.

            99.2  Press Release related to executive changes.

                                SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the Registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.

                              Dade Behring Inc.


                              By: /s/Glenn R. Richter
                              Title: Senior Vice President and
                                     Chief Financial Officer

Dated:  May 11, 1999
<PAGE>


N E W S   R E L E A S E
                                                 DADE BEHRING
DADE BEHRING INC.
1717 Deerfield Road
P.O. Box 778
Deerfield, IL  60015-0778
847.267.5300

For Immediate Release

Contact:  Fred Nachman for Dade Behring, 312-832-9300 x202
          Joe Grillo for Bain Capital, 617-951-0000

   Dade Behring Announces Hoechst AG Will Increase Ownership Position


     DEERFIELD, Ill. (May 3, 1999) - Dade Behring Inc., a leading global

manufacturer and marketer of products and systems serving clinical

diagnostics, today announced that Hoechst AG will increase its economic

ownership in the company.  Hoechst AG, headquartered in Frankfurt,

Germany, currently owns a 32.5 percent share of Dade Behring.


     The increased ownership will result from a share repurchase program

under which Dade Behring will repurchase a portion of its outstanding

stock from its non-Hoechst AG shareholders.  The share repurchase

program will be accomplished through a recapitalization and refinancing.

The non-Hoechst AG shareholders - Bain Capital, Goldman Sachs and

company management - will continue to be the controlling shareholder

group.


     With 1998 revenues of approximately $1.3 billion, Dade Behring is

among the largest clinical diagnostics companies worldwide and provides

the broadest available offering of products and systems for diagnostics

testing.  Dade Behring is headquartered in Deerfield, Illinois, has

operations in 39 countries and works through distributors in other

regions.

##


N E W S   R E L E A S E
                                                 DADE BEHRING
DADE BEHRING INC.
1717 Deerfield Road
P.O. Box 778
Deerfield, IL  60015-0778
847.267.5300

For Immediate Release

Contact:  Fred Nachman for Dade Behring, 312-832-9300 x202


                    Dade Behring Names Reid-Anderson

                   President, Chief Operating Officer
                                 -----

   Other Executives Are Appointed in "Customer-Focused" Organization



     DEERFIELD, Ill. (May 4, 1999) - Dade Behring Inc., a leading global

manufacturer and marketer of products and systems serving clinical

diagnostics, today announced the appointment of James Reid-Anderson, 40,

as president and chief operating officer.



     In this new position, Reid-Anderson will be responsible for Dade

Behring's global sales and service, research and development, marketing,

operations, regulatory affairs and quality assurance, and human-

resources management.  He reports to Chief Executive Officer Steven W.

Barnes.


     Reid-Anderson joined Dade Behring as executive vice president and

chief financial officer in 1996.  He assumed the added role of chief

administrative officer in 1997.  Prior to joining Dade Behring, he was

chief operating officer and chief administrative officer of Wilson

Sporting Goods in Chicago from 1994 to 1996.  Previous to that, he held

executive positions with Pepsico Inc., Grand Metropolitan PLC and Mobil

Oil Corporation.  He earned a commerce degree with honors from the

University of Birmingham in England and is a fellow of the Chartered

Association of Certified Accountants.


     "Jim's new responsibilities as president and chief operating

officer are an extension and a reflection of the superb job he has done
<PAGE>
in helping build one of the leading global diagnostics companies,"

Barnes said.  "In the years ahead, he will continue to be instrumental

in our focus on providing leading products and unequalled service to our

customers within the clinical diagnostics field worldwide."


     Dade Behring also announced a number of other executive

appointments, reporting to Reid-Anderson.  These relate to an

organizational streamlining of global product management and geographic

operations, designed to enhance the company's leadership position:


  .  Robert Brightfelt, 55, becomes president, Global Products,

     responsible for global research and development, marketing, and

     operations across the company's uniquely wide range of products and

     systems for clinical chemistry, immunochemistry, hemostasis,

     microbiology, infectious-disease diagnostics, plasma-protein

     analysis, cardiac diagnostics and drug monitoring.  He had been

     group president for Chemistry products.  He has 33 years of

     experience in health care and diagnostics with Dade Behring and

     DuPont Diagnostics.  He holds an M.B.A. degree from the University

     of Georgia and an M.S. and B.S. with distinction from the

     University of Nebraska.


  .  Marc N. Casper, 31, becomes president for the Americas,

     responsible for the company's sales, service and marketing

     operations in that region.  He had been executive vice president

     for Europe, Asia and Intercontinental.  Casper has been with Dade

     Behring since 1995.  He holds an M.B.A. degree with high

     distinction from the Harvard Business School and a B.A. in

     economics from Wesleyan University.


  .  Donal Quinn, 43, becomes president for Europe, Middle East and

     Africa.  He had been group president for Biology products since

     joining Dade Behring in 1998.  Previously, he has more than 20

     years of health-care industry experience, including executive
<PAGE>
     positions with Mallinckrodt Medical and Abbott Laboratories.  He

     earned a B.S. degree in economics from Cork University in Ireland.


  .  Hiroshi Uchida, 39, becomes president for Asia.  He had been

     vice president and general manager for the Asia-Pacific region

     since joining Dade Behring in 1997.  His previous experience

     includes senior positions with Arthur D. Little and Bain

     Consulting.  He holds Ph.D. and M.A. degrees from Harvard

     University and a B.A. degree from Brown University.


     In addition, the company has appointed Glenn Richter, 37, as chief

financial officer, reporting to Barnes.  Richter has been with the

company since 1997, most recently as senior vice president and corporate

controller.  Prior to joining Dade Behring, his 11 years of executive

experience included positions with the Frito-Lay Company and McKinsey &

Company.  He holds an M.B.A. degree from Duke University and a B.B.A.

degree from the George Washington University.


     "Each of these appointments is important to our continuing

evolution in building the most customer-focused diagnostics company

worldwide," said Barnes.  Since the merger of Dade International and

Behring Diagnostics in October 1997, we have been tremendously

successful in leveraging our combined capabilities to help clinical

laboratories contribute to improved patient outcomes while increasing
<PAGE>
laboratory productivity.  Our focus is on being today's best resource

for the customers we serve."


     With 7,100 employees and 1998 revenues of approximately $1.3

billion, Dade Behring is among the largest clinical diagnostics

companies worldwide and provides the broadest available offering of

products and systems for diagnostics testing.  Many of the company's

products hold leadership positions in markets around the world.  Dade

Behring is headquartered in Deerfield, Illinois, has operations in 39

countries and works through distributors in other regions.



     ##



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission